The justification for initiating the insulin therapy was: the persistence of fasting blood glucose levels > 200 mg/dL (41%), A1c > 9% (35%), the presence of catabolism (17%) and any contraindicating factor to the oral agents (e.g. renal dysfunction). Here, INS is linked to Abnormal renal physiology.